2, 4DI (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders

Details for Australian Patent Application No. 2004220338 (hide)

Owner Novartis AG

Inventors Miyake, Takahiro; Matsuura, Naoko; Kawahara, Eiji; Garcia-Echeverria, Carlos; Ohmori, Osamu; Kanazawa, Takanori; Umemura, Ichiro; Masuya, Keiichi

Agent Davies Collison Cave

Pub. Number AU-B-2004220338

PCT Pub. Number WO2004/080980

Priority 0319227.5 15.08.03 GB; 0322370.8 24.09.03 GB; 0305929.2 14.03.03 GB

Filing date 12 March 2004

Wipo publication date 23 September 2004

Acceptance publication date 9 October 2008

International Classifications

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 35/00 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/080980 Priority application(s): WO2004/080980

9 October 2008 Application Accepted

  Published as AU-B-2004220338

5 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004220339-Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies

2004220327-Pyridyloxymethyl and benzisoxazole azabicyclic derivatives